Palomino Laboratories (PALX) EPS (Basic) (2023 - 2025)

Palomino Laboratories has disclosed EPS (Basic) across 3 years of filings, most recently posting $0.41 for Q4 2025.

• EPS (Basic) for Q4 2025 came in at $0.41, up 3818.18% year-over-year; the trailing twelve-month figure through Dec 2025 was -$0.58 (down 2048.15% YoY), and the FY2025 annual result was -$0.47, down 4181.82% from the prior year.
• EPS (Basic) came in at $0.41 for Q4 2025 at Palomino Laboratories, up from -$0.54 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $0.41 in Q4 2025 to a low of -$0.54 in Q3 2025.
• The 3-year median for EPS (Basic) is -$0.01 (2023), against an average of -$0.05.
• Peak annual rise in EPS (Basic) reached 3818.18% in 2025, while the deepest fall reached 773800.83% in 2025.
• Palomino Laboratories' EPS (Basic) stood at -$0.01 in 2023, then slumped by 57.14% to -$0.01 in 2024, then soared by 3818.18% to $0.41 in 2025.
• The last three EPS (Basic) figures came in at $0.41 (Q4 2025), -$0.54 (Q3 2025), and -$0.01 (Q2 2025), per Business Quant data.